Tikagrelor (Indonesian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tikagrelor" in Indonesian language version.

refsWebsite

Global rank Indonesian rank

3europa.eu

68^th place

182^nd place

3nih.gov

4^th place

13^th place

2tga.gov.au

3,984^th place

4,575^th place

2fda.gov

447^th place

792^nd place

1canada.ca

1,712^th place

7,978^th place

1doi.org

2^nd place

4^th place

1archive-it.org

910^th place

671^st place

1kardioipdrscm.com

low place

2,955^th place

archive-it.org (Global: 910^th place; Indonesian: 671^st place)

wayback.archive-it.org

"FDA approves blood-thinning drug Brilinta to treat acute coronary syndromes" (Press release). U.S. Food and Drug Administration (FDA). 20 July 2011. Diarsipkan dari asli tanggal 12 January 2017.

canada.ca (Global: 1,712^th place; Indonesian: 7,978^th place)

"Product monograph brand safety updates". Health Canada. February 2024. Diakses tanggal 24 March 2024.

doi.org (Global: 2^nd place; Indonesian: 4^th place)

Jacobson KA, Boeynaems JM (July 2010). "P2Y nucleotide receptors: promise of therapeutic applications". Drug Discovery Today. 15 (13–14): 570–578. doi:10.1016/j.drudis.2010.05.011. PMC 2920619. PMID 20594935.

europa.eu (Global: 68^th place; Indonesian: 182^nd place)

ema.europa.eu

"Brilique EPAR". European Medicines Agency. 17 September 2018. Diakses tanggal 18 May 2022. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"Assessment Report for Brilique" (PDF). European Medicines Agency. January 2011.
European Public Assessment Report Possia

fda.gov (Global: 447^th place; Indonesian: 792^nd place)

fda.gov

"FDA approves blood-thinning drug Brilinta to treat acute coronary syndromes" (Press release). U.S. Food and Drug Administration (FDA). 20 July 2011. Diarsipkan dari asli tanggal 12 January 2017.

accessdata.fda.gov

"Drug Approval Package: Brilinta (ticagrelor) NDA #022433". U.S. Food and Drug Administration (FDA). 22 August 2011. Diakses tanggal 22 May 2021.

kardioipdrscm.com (Global: low place; Indonesian: 2,955^th place)

Salim, S (15 February 2015). "Ticagrelor, Harapan Baru Dalam Prevensi Sekunder Pada Pasien Infark Miokard". Kardioipdrscm.com.^{[pranala nonaktif permanen]}

nih.gov (Global: 4^th place; Indonesian: 13^th place)

dailymed.nlm.nih.gov

"Brilinta- ticagrelor tablet". DailyMed. 10 August 2021. Diakses tanggal 19 May 2022.

ncbi.nlm.nih.gov

Jacobson KA, Boeynaems JM (July 2010). "P2Y nucleotide receptors: promise of therapeutic applications". Drug Discovery Today. 15 (13–14): 570–578. doi:10.1016/j.drudis.2010.05.011. PMC 2920619. PMID 20594935.

pubmed.ncbi.nlm.nih.gov

Jacobson KA, Boeynaems JM (July 2010). "P2Y nucleotide receptors: promise of therapeutic applications". Drug Discovery Today. 15 (13–14): 570–578. doi:10.1016/j.drudis.2010.05.011. PMC 2920619. PMID 20594935.

tga.gov.au (Global: 3,984^th place; Indonesian: 4,575^th place)

"Updates to the Prescribing Medicines in Pregnancy database". Therapeutic Goods Administration (TGA). 12 May 2022. Diakses tanggal 13 May 2022.
"Ticalor; Blooms The Chemist Ticagrelor; Apo-Ticagrelor; Ticagrelor Arx (Accelagen Pty Ltd)". Therapeutic Goods Administration (TGA). 11 November 2022. Diakses tanggal 9 April 2023.

Tikagrelor (Indonesian Wikipedia)

archive-it.org (Global: 910th place; Indonesian: 671st place)

wayback.archive-it.org

canada.ca (Global: 1,712th place; Indonesian: 7,978th place)

doi.org (Global: 2nd place; Indonesian: 4th place)

europa.eu (Global: 68th place; Indonesian: 182nd place)